Cargando…
Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients
Circulating MFAP4 is a relevant biomarker to identify COPD patients at risk of death and cardiovascular comorbidity after smoking cessation http://ow.ly/6vnL30o8t1g
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469069/ https://www.ncbi.nlm.nih.gov/pubmed/31024964 http://dx.doi.org/10.1183/23120541.00021-2019 |
| _version_ | 1783411568336175104 |
|---|---|
| author | Johansson, Sofie Lock Wulf-Johansson, Helle Schlosser, Anders Titlestad, Ingrid L. Miller, Bruce Tal-Singer, Ruth Holmskov, Uffe Vestbo, Jørgen Sørensen, Grith Lykke |
| author_facet | Johansson, Sofie Lock Wulf-Johansson, Helle Schlosser, Anders Titlestad, Ingrid L. Miller, Bruce Tal-Singer, Ruth Holmskov, Uffe Vestbo, Jørgen Sørensen, Grith Lykke |
| author_sort | Johansson, Sofie Lock |
| collection | PubMed |
| description | Circulating MFAP4 is a relevant biomarker to identify COPD patients at risk of death and cardiovascular comorbidity after smoking cessation http://ow.ly/6vnL30o8t1g |
| format | Online Article Text |
| id | pubmed-6469069 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64690692019-04-25 Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients Johansson, Sofie Lock Wulf-Johansson, Helle Schlosser, Anders Titlestad, Ingrid L. Miller, Bruce Tal-Singer, Ruth Holmskov, Uffe Vestbo, Jørgen Sørensen, Grith Lykke ERJ Open Res Original Research Letters Circulating MFAP4 is a relevant biomarker to identify COPD patients at risk of death and cardiovascular comorbidity after smoking cessation http://ow.ly/6vnL30o8t1g European Respiratory Society 2019-04-15 /pmc/articles/PMC6469069/ /pubmed/31024964 http://dx.doi.org/10.1183/23120541.00021-2019 Text en Copyright ©ERS 2019 http://creativecommons.org/licenses/by-nc/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
| spellingShingle | Original Research Letters Johansson, Sofie Lock Wulf-Johansson, Helle Schlosser, Anders Titlestad, Ingrid L. Miller, Bruce Tal-Singer, Ruth Holmskov, Uffe Vestbo, Jørgen Sørensen, Grith Lykke Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients |
| title | Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients |
| title_full | Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients |
| title_fullStr | Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients |
| title_full_unstemmed | Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients |
| title_short | Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients |
| title_sort | plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in copd patients |
| topic | Original Research Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469069/ https://www.ncbi.nlm.nih.gov/pubmed/31024964 http://dx.doi.org/10.1183/23120541.00021-2019 |
| work_keys_str_mv | AT johanssonsofielock plasmamicrofibrillarassociatedprotein4isnotprognosticofemphysemaprogressionbutisassociatedwithcardiovasculardiseasehistoryandmortalityincopdpatients AT wulfjohanssonhelle plasmamicrofibrillarassociatedprotein4isnotprognosticofemphysemaprogressionbutisassociatedwithcardiovasculardiseasehistoryandmortalityincopdpatients AT schlosseranders plasmamicrofibrillarassociatedprotein4isnotprognosticofemphysemaprogressionbutisassociatedwithcardiovasculardiseasehistoryandmortalityincopdpatients AT titlestadingridl plasmamicrofibrillarassociatedprotein4isnotprognosticofemphysemaprogressionbutisassociatedwithcardiovasculardiseasehistoryandmortalityincopdpatients AT millerbruce plasmamicrofibrillarassociatedprotein4isnotprognosticofemphysemaprogressionbutisassociatedwithcardiovasculardiseasehistoryandmortalityincopdpatients AT talsingerruth plasmamicrofibrillarassociatedprotein4isnotprognosticofemphysemaprogressionbutisassociatedwithcardiovasculardiseasehistoryandmortalityincopdpatients AT holmskovuffe plasmamicrofibrillarassociatedprotein4isnotprognosticofemphysemaprogressionbutisassociatedwithcardiovasculardiseasehistoryandmortalityincopdpatients AT vestbojørgen plasmamicrofibrillarassociatedprotein4isnotprognosticofemphysemaprogressionbutisassociatedwithcardiovasculardiseasehistoryandmortalityincopdpatients AT sørensengrithlykke plasmamicrofibrillarassociatedprotein4isnotprognosticofemphysemaprogressionbutisassociatedwithcardiovasculardiseasehistoryandmortalityincopdpatients |